May 18, 2017
Antiva Biosciences, a spinout of UC San Diego, closed a $22M Series C financing in March. Antiva is a clinical stage biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by Human Papilloma Virus (HPV) infection. Osage University Partners, a venture capital firm partnered with UC San…
September 27, 2018
Scientists have known that bacteria produce small spherical versions of themselves. Lacking basic materials to reproduce or function like normal cells, the natural role of minicells—which protrude like budding balloons off the ends of bacteria—has remained a mystery. Now, researchers at UC San Diego have demonstrated for the first time…
September 19, 2014
Researchers at the University of California, San Diego School of Medicine, University of Pittsburgh and elsewhere describe the first human tests of using a perfluorocarbon (PFC) tracer in combination with non-invasive magnetic resonance imaging (MRI) to track therapeutic immune cells injected into patients with colorectal cancer.
September 7, 2016
…to help shape the scientific mission at the National Cancer Institute (NCI) of Vice President Joe Biden’s National Cancer Moonshot Initiative, they were given five months to draft guidelines to accelerate cancer research, prevention and care. On Wednesday, the National Cancer Advisory Board approved the Blue Ribbon Panel’s 10 recommendations.
July 23, 2020
Cancer Isn’t Taking a Timeout for COVID-19; Neither are Clinical Trials Before the COVID-19 pandemic, physician-scientists Drs. Ezra Cohen, Catriona Jamieson, Dan Kaufman and Stephen Schoenberger discussed one of 195 cancer therapeutic clinical trials available at UC San Diego Health. These life-saving studies continue to be offered. With additional safety…
October 11, 2021
More than 100 UC San Diego Health physicians in 48 specialties have been named “Top Docs” in the 2021 San Diego Magazine “Physicians of Exceptional Excellence” survey.
March 21, 2022
UC San Diego Health is now administering Evusheld to eligible, immunocompromised patients to protect against the COVID-19 virus.
May 16, 2019
In its first-ever assessment of biomedical institutions around the world, based upon published research in a targeted set of high-quality scientific journals, the 2019 Nature Index ranked University of California San Diego ninth among the top 200 institutions in biomedical sciences worldwide.
September 19, 2016
…of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy. The researchers identified a molecular switch that controls immune suppression, opening the possibility to further improving and refining emerging immunotherapies that boost the body’s own abilities to fight diseases ranging from cancer…
October 31, 2023
Matthew and Iris Strauss and the Strauss Family Foundation have donated a world-class collection of contemporary art to the University of California San Diego. The collection is comprised of more than 100 pieces by artists from around the globe.
